| Date | Title | Description |
| 21.04.2022 | Terran Biosciences announces licensing deal with Sanofi for two late-stage CNS pipeline assets | Terran to advance the development of two of Sanofi's Phase 3 CNS therapeutics
Transaction includes worldwide exclusive rights for development and commercialization in all fields of use
NEW YORK, April 21, 2022 /PRNewswire/ -- Terran Bioscie... |
| 16.03.2022 | Terran Biosciences announces licensing deal with Columbia University for exclusive worldwide rights to proprietary CNS biomarker software platform | NEW YORK, March 16, 2022 /PRNewswire/ -- Terran Biosciences, Inc. ("Terran"), a biotech platform company dedicated to the development of transformational therapeutics and technologies for neurological and psychiatric diseases, has... |
| 16.03.2022 | Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration | Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity
Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France
Glooko, a leading provider of remote patient monitoring and data management solutions for diabet... |
| 11.03.2022 | Terran Biosciences announces acquisition of a portfolio of novel CNS therapeutics from Concert Pharmaceuticals | NEW YORK, March 11, 2022 /PRNewswire/ -- Terran Biosciences ("Terran"), a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric diseases, has entered into an agreem... |
| 09.03.2022 | Terran Biosciences and University of Maryland, Baltimore announce exclusive licensing deal for a portfolio of patents and data supporting novel innovation in the psychedelic therapeutic space | NEW YORK, March 9, 2022 /PRNewswire/ -- Terran Biosciences, Inc. ("Terran") has entered into an agreement with the University of Maryland, Baltimore ("UMB") for a worldwide exclusive license to develop and commercialize ... |
| 26.08.2019 | Presight Capital raises $80M fund to connect US startups with Europe | Presight Capital, the international venture arm of Apeiron Investment Group, is announcing that it’s closed its first fund of $80 million.
Apeiron is the family office of German entrepreneur Christian Angermayer (pictured above), who previo... |
